Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 01, 2025 07:48 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); Flywire Corporation (NASDAQ: FLYW); Replimune Group, Inc. (NASDAQ: REPL); and Sable Offshore Corporation (NYSE: SOC): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Centene Corporation (NYSE: CNC): Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation (NYSE: CNC). The...
July 30, 2025 08:49 ET | Source: Grabar Law Office

Important Notice to Short and Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Flywire Corporation (NASDAQ: FLYW); Replimune Group, Inc. (NASDAQ: REPL); and Sable Offshore Corporation (NYSE: SOC): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers and directors of DoubleVerify...
July 28, 2025 10:00 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, July 28, 2025 (GLOBE NEWSWIRE) -- Alto Neuroscience, Inc. (NYSE: ANRO): Grabar Law Office is investigating claims on behalf of shareholders of Alto Neuroscience,...
July 27, 2025 09:58 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, July 27, 2025 (GLOBE NEWSWIRE) -- Alto Neuroscience, Inc. (NYSE: ANRO): Grabar Law Office is investigating claims on behalf of shareholders of Alto Neuroscience, Inc. (NYSE: ANRO)....